Pietro Leccese

TL;DR: The recommendations on the medical management of mucocutaneous, joint, eye, vascular, neurological and gastrointestinal involvement of BS were modified; five overarching principles and a new recommendation about the surgical management of vascular involvement were added.

TL;DR: The majority of studies related to major organ involvement that informed the updated EULAR recommendations for the management of BS were observational studies, including studies with beneficial results for refractory uveitis.

TL;DR: The results of this study suggest that patients with Behçet's disease showing a scarce response or adverse events to infliximab may successfully be treated with adalimumab, regardless of the reason for switching.

TL;DR: The findings suggest a less satisfactory performance of the CASPAR criteria when applied in early PsA, which could mainly depend on the small proportion of patients fulfilling the radiologic criterion.

TL;DR: RCTs comprised more than a half (21/37, 57%) of the sources included in the evidence synthesis related to skin, mucosa and joint involvement applicable for the EULAR Recommendations for the management of BS.